Sleep May Deserve a Place in Cancer Prevention Guidelines, Researchers Argue

When the American Heart Association updated its flagship cardiovascular health framework in 2022, expanding the well-known Life’s Simple 7 into Life’s Essential 8, the most eye-catching addition was sleep. For the first time, a major public health guideline formally told adults to get seven to nine hours of sleep each night, treating sleep duration as a pillar of heart health alongside diet, exercise, smoking, body weight, blood glucose, blood lipids, and blood pressure. Now, a large cohort study has tested whether that same score predicts cancer risk, and the results have prompted a pointed scientific debate about whether cardiovascular metrics can simply be borrowed for oncology.

The study in question, published in BMC Cancer by Yang and colleagues, applied the Life’s Essential 8 score to more than 330,000 participants from the UK Biobank, one of the world’s largest biomedical databases. The team calculated a composite cardiovascular health score for each participant, in which every component is rated from 0 to 100 and then averaged, and tracked cancer diagnoses and deaths over follow-up. Their headline finding was striking: each 10-point increase in the overall Life’s Essential 8 score was associated with a 3 percent lower risk of incident cancer in men and a 4 percent lower incidence in women. On its face, the message seemed clear — living a heart-healthy life also appears to lower cancer risk.

But a new commentary published in the same journal by Charlie Zhong and Erika Rees-Punia of the American Cancer Society’s Population Science division and Sidney M. Donzella of the University of Washington argues that the picture is more complicated than that headline suggests. Their central concern is not with the finding itself, which they describe as compelling, but with the tool used to obtain it. Life’s Essential 8, they write, was designed to capture cardiovascular disease risk, and there is no guarantee that its components map cleanly onto the biology of cancer, a family of more than a hundred distinct diseases with often disparate causes.

The sharpest disagreement concerns sleep. In the Life’s Essential 8 scoring scheme, individuals who sleep seven to nine hours per night receive the maximum score of 100 points. Those sleeping nine to ten hours get 90 points, six to seven hours earn 70 points, five to six hours and ten or more hours receive 40 points, four to five hours score 20, and under four hours earns zero. This scoring reflects what the American Heart Association describes as an inverse U-shaped relationship between sleep duration and health outcomes: risk rises at both extremes, but moderate sleep sits at the bottom of the curve. That shape is well supported for cardiovascular disease, where both very short and very long sleep are associated with elevated risk.

For cancer, however, the evidence points to a different geometry. Zhong and colleagues point to pooled analyses of Japanese cohorts, systematic reviews and meta-analyses of sleep duration and cancer incidence and mortality, and their own analysis of the Cancer Prevention Study-II, all of which more commonly observe a J-shaped association between sleep duration and cancer outcomes. In a J-shaped curve, the risk of long sleep rises more steeply than the risk of short sleep, meaning that the penalty for sleeping too much is greater than the penalty for sleeping too little. A scoring system built around an inverse U therefore treats the two tails of the distribution differently than the cancer literature would suggest they should be treated.

The mismatch has practical consequences. In the supplementary tables of the original study, sleep was associated with the fewest cancer types of any component in the Life’s Essential 8 score, a pattern the commentary authors attribute at least in part to how sleep is scored. If the true relationship between sleep and cancer is J-shaped rather than inverse U-shaped, then a scoring scheme that rewards nine hours of sleep nearly as much as eight may obscure real associations that a cancer-specific metric would detect. The commentary even notes evidence from a 2022 Nature study showing that circulating tumor cells in breast cancer spread more efficiently during sleep, hinting that the biology of sleep and cancer progression may be more intricate than a simple duration threshold can capture.

The other components of Life’s Essential 8 fare somewhat better in the cancer context. Higher scores for diet, physical activity, smoking status, and body mass index were consistently associated with decreased cancer risk in the UK Biobank analysis, which is unsurprising given that these behaviors are already established cancer prevention targets. But the clinical components of the score tell a more nuanced story. Blood glucose, for example, is scored in Life’s Essential 8 largely through the lens of diabetes, and diabetes is indeed associated with increased risk of liver, pancreatic, endometrial, colorectal, breast, and bladder cancers — many of which showed reduced risk with better glucose scores in the study’s component-level analyses.

Prostate cancer, however, breaks the pattern. Diabetes is associated with reduced risk of prostate cancer, potentially because the condition is linked to lower testosterone levels. Consistent with that biology, the UK Biobank study found that higher blood glucose scores — which indicate better glycemic control and no diabetes — were associated with increased prostate cancer risk, and the overall Life’s Essential 8 score was likewise associated with higher prostate cancer risk. In other words, a metric that rewards cardiovascular health may inadvertently flag a risk profile that is protective for one cancer and harmful for another. The commentary authors cite this as a textbook example of why a single composite score, built for the heart, cannot be assumed to generalize across the heterogeneous landscape of malignancies.

None of this diminishes the value of the original study, which the commentary authors treat as a genuine contribution rather than a flawed exercise. Their argument is narrower and more constructive: if sleep and other components of cardiovascular health are to be used in cancer research and, eventually, cancer prevention advice, the field needs metrics designed for that purpose. The American Cancer Society already publishes guidelines for diet, physical activity, and sedentary time for cancer prevention, and the commentary suggests that sleep duration may warrant consideration for inclusion in future revisions of such guidance, given its established links to those same behaviors and the growing mechanistic and epidemiologic evidence connecting sleep to cancer outcomes.

The commentary also acknowledges that sleep is more than a number of hours. Sleep quality, sleep latency, timing, and consistency are all dimensions of sleep health that remain understudied in relation to cancer, and any future guideline would need to grapple with that complexity rather than reduce sleep to a single duration threshold. Still, the authors conclude that the weight of evidence — from their own work on sleep and cancer mortality, from pooled cohort analyses, and from the UK Biobank findings themselves — supports treating sleep duration as a modifiable lifestyle factor in cancer prevention. Whether cancer-focused guidelines ultimately adopt sleep, and how they score it, will depend on further research that disentangles the relationship between sleep and individual cancer types, rather than borrowing a cardiovascular template wholesale.

Subject of Research: The suitability of the Life's Essential 8 cardiovascular health score, particularly its sleep component, for assessing cancer risk and informing cancer prevention guidelines

Article Title: Comment on “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,417 United Kingdom participants” and the inclusion of sleep in cancer focused guidelines

Article References: Zhong, C., Donzella, S. M., & Rees-Punia, E. (2026). Comment on “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,417 United Kingdom participants” and the inclusion of sleep in cancer focused guidelines. BMC Cancer, 26(1), Article 1077. https://doi.org/10.1186/s12885-026-16941-z

Image Credits: AI Generated

DOI: 10.1186/s12885-026-16941-z

Keywords: cancer prevention, sleep duration, Life's Essential 8, cardiovascular health, UK Biobank, American Heart Association, American Cancer Society, sleep health, cancer risk, health guidelines, epidemiology, prostate cancer